Episodes (Page 3)
✨
Discussed beta blockers' role post-MI, even with good heart function.
✨
Defined invasive fungal disease and identified high-risk patients.
✨
Contrasted A1c limitations with Continuous Glucose Monitor (CGM) data.
✨
Discussed imaging choices (U/S, CT, MRI) for IR consultations.
✨
Reviewed reversible causes and fiber's role in constipation.
✨
Examined HIV prevention efficacy versus effectiveness.
✨
Explained Lipoprotein(a) (Lp(a)) beyond standard lipid panels.
✨
Introduced a new framework for clots beyond provoked/unprovoked.
#172 Microplastics and Macro CV Health Problems: Beyond Journal Club on APACHe Study with NEJM Group
✨
Investigated microplastics' potential impact on human health.
✨
Explored music therapy's role in end-of-life care.
✨
Addressed incidental fibrosis on CT and interpreting prone imaging.
✨
Clarified SPEP, UPEP, immunofixation, and free light chains.
✨
Differentiated immune checkpoint inhibitor adverse events (IrAEs) from other conditions.
✨
Reviewed anion gap metabolic acidosis concepts.
✨
Evaluated evidence for PPIs in mechanically ventilated patients.
✨
Highlighted reasons for missing peripheral arterial disease (PAD) diagnoses.
✨
Differentiated TPN and PPN indications and compositions.
✨
Outlined limitations of urine drug screening (UDS) in primary care.
✨
Addressed financial barriers to hospice care.
✨
Examined the MINT trial's impact on anemia treatment in MI.